Image source

The munKNEE "Seed-to-Sale" Pot Stocks Index went UP +10.5% this past week with each of the sub indexes surpassing the +10% threshold. This article has the details.

The munKNEE "Seed-to-Sale" Pot Stocks Index consists of: 

• the 20 non-ancillary (i.e. pure-play) vertically integrated cannabis companies whose stocks
  • trade for at least US$1/share (4Front Ventures is the only exception),
  • have a market cap of at least US$200M, and
  • trade on one or more of the Canadian and/or American stock exchanges.
• The Index is made up of two categories, namely:
  • the Pure-Play Canadian LP Pot Stock Sub-Index of 5 Canadian Licensed Producers and
  • the Pure-Play American MSO Pot Stock Sub-Index of 15 American Multi-State Operators
    • which, in total, represent approximately 10% of the total universe of 217 cannabis and ancillary companies currently trading.
• The non-tradable indices gives each constituent the same importance to provide a comparison of the performance of each with the others and the stated sector as a whole.

You will note that each constituent in the analyses below has 6 areas of additional information that are imperative for any individual considering investing in this sector:

1. The company name is hyperlinked to its website to provide you with a description of the company and an analysis of its stock.
2. The trading symbol is hyperlinked to additional financial data and commentary on the company (where available).
3. The percentage change YTD is hyperlinked to a chart of the company's stock performance.
4. The Chance of Financial Distress percentage is sourced from macroaxis.com (visit the site and type in the stock symbol to obtain detailed financial data on the health of the company).
5. The buy/hold/sell analyst consensus is sourced from stockanalysis.com ((visit the site and type in the stock symbol to obtain a detailed consensus of their recommendations and projections). 
6. The articles are sourced from Stone Fox Capital and TalkMarkets to provide the latest analyses/commentaries.

The munKNEE Pure-Play Canadian LP Pot Stock Sub-Index

Below is how the Canadian Licensed Producer constituents performed this past week, in descending order, with their year-to-date (YTD) performances in brackets:

1. Canopy Growth (CGC): +17.8%; (-18.4% YTD)
   • Chance of Financial Distress in next 2 years: +61%
   • Analyst Consensus: 26 stock analysts currently rate CGC as a SELL but forecast an increase of 41.6% in the next 12 months.
2. Cronos (CRON): +16.5%; (-7.9% YTD)
   • Chance of Financial Distress in next 2 years: 50%
   • Analyst Consensus: 20 stock analysts currently rate CRON as a SELL but forecast an increase of 55.8% in the next 12 months.
3. Organigram (OGI): +13.4%; (-13.1% YTD)
   • Chance of Financial Distress in next 2 years: less than 1%
   • Analyst Consensus: 17 stock analysts currently rate OGI as a BUY and forecast an increase of 84.4% in the next 12 months.
4. Aurora (ACB): +12.3%;  (-34.4% YTD)
   • Chance of Financial Distress in next 2 years: 49%
   • Analyst Consensus: 18 stock analysts currently rate ACB as a SELL but forecast an increase of 49.6% in the next 12 months.
5. Tilray (TLRY): +6.2%; (-21.6% YTD)
   • Chance of Financial Distress in next 2 years: +63%
   • Analyst Consensus: 25 stock analysts currently rate TLRY as a HOLD and forecast an increase of 67.7% in the next 12 months.

The LP Sub-Index went UP +13.0% this past week but remains DOWN -20.6% YTD and DOWN a whopping -86.4% from its high in 2021.

The munKNEE Pure-Play American MSO Pot Stock Sub-Index

Below is how the American Multi-State Operator constituents performed this past week, in descending order, with their year-to-date performances in brackets:

1. Valens (VLNS): +28.6%; (+0.8% YTD)
   • Chance of Financial Distress in next 2 years: 50%
   • Analyst Consensus: 13 stock analysts currently rate VLNS as a BUY and foreca an increase of 261.9% in the next 12 months.
   • Recent Article Analyses/Commentaries: The Valens Company's Q4 Financials Results Were Very Disappointing
2. Columbia Care (CCHWF): +15.4%; (+10.1% YTD)
   • Chance of Financial Distress in next 2 years: +74%
   • Analyst Consensus: None following CCHWF
3. Curaleaf (CURLF): +15.0%; (-25.1% YTD)
   • Chance of Financial Distress in next 2 years: 39%
   • Analyst Consensus: 23 stock analysts currently rate CURLF as a BUY and forecast an increase of 237.7% in the next 12 months.
   • Recent Analyses/Commentaries: Curaleaf: Trend Remains Up
4. Green Thumb (GTBIF): +15.0%; (-18.5% YTD)
   • Chance of Financial Distress in next 2 years: less than 1%
   • Analyst Consensus: 23 stock analysts currently rate GTBIF as a BUY and forecast an increase of 155.9% in the next 12 months.
   • Recent Analyses/Commentaries: Green Thumb: Ignore Noise
5. TerrAscend (TRSSF): +15.0%; (-10.9% YTD)
   • Chance of Financial Distress in next 2 years: +60%
   • Analyst Consensus: None following TRSSF
   • Recent Articles/Analyses/Commentaries: TerrAscend Bounces Higher On Q4 Financial Results But Remains Down YTD and TerrAscend: Find A Better MSO Stock
6. Cresco (CRLBF): +14.8%; (-4.6% YTD)
   • Chance of Financial Distress in next 2 years: +62%
   • Analyst Consensus: None following CRLBF
7. Goodness Growth (GDNSF): +13.5%; (+27.5% YTD)
   • Chance of Financial Distress in next 2 years: +63%
   • Analyst Consensus: None following GDNSF
8. Verano (VRNOF): +11.2%; (-17.5% YTD)
   • Chance of Financial Distress in next 2 years: 39%
   • Analyst Consensus: None following VRNOF
   • Recent Article Analyses/Commentaries: Verano: Get This Profitable Cannabis Player At A Special Discount
9. Trulieve (TCNNF): +8.4%; (-23.1% YTD)
   • Chance of Financial Distress in next 2 years: 36%
   • Analyst Consensus: 23 stock analysts currently rate TCNNF as a BUY and forecast an increase of 257.5% in the next 12 months.
10. Acreage (ACRDF/ACRHF): +4.5%; (+13.3% YTD)
    • Chance of Financial Distress in next 2 years: +70%
    • Analyst Consensus: None following Acreage
    • Recent Article Analyses/Commentaries: Acreage Holdings Q4 Financial Results Show Dramatic Increase In Net Loss
11. Ascend Wellness (AAWH): +4.5%; (-36.4% YTD)
    • Chance of Financial Distress in next 2 years: 50%
    • Analyst Consensus: 5 stock analysts currently rate AAWH as a BUY.
    • Recent Article Analyses/Commentaries:
      • Ascend Wellness Q4 Metrics Down Across The Board and Ascend Wellness: New York Is Only A Bonus 
12. Jushi (JUSHF): +4.2%; (-1.5% YTD)
    •  Chance of Financial Distress in next 2 years: +62%
    • Analyst Consensus: None following JUSHI
    • Latest Article Analyses/Commentaries: Jushi Is Starting To Look Like One Of The Best Value Plays In The U.S. Cannabis Sector
13. Ayr Wellness (AYRWF): +2.8%; (-19.7% YTD)
    • Chance of Financial Distress in next 2 years: +62%
    • Analyst Consensus: 6 stock analysts currently rate AYRWF as a BUY
    • Recent Article Analyses/Commentaries: AYR Wellness, Inc. Q4 Financials Show Little Improvement
14. Planet 13 (PLNHF): -7.6%; (-30.1% YTD)
    • Chance of Financial Distress in next 2 years: 25%
    • Analyst Consensus: 10 stock analysts currently rate PLNHF as a BUY and forecast an increase of 177.7% in the next 12 months.
15. 4Front Ventures (FFNTF): -11.3%; (-29.7% YTD)
    • Chance of Financial Distress in next 2 years: 40%
    • Analyst Consensus: None following FFNTF

The MSO Sub-Index went UP +10.0% this past week but is still DOWN -17.3% YTD and DOWN -61.6% from its high in 2021.

In sum total, the munKNEE "Seed-to-Sale" Pot Stocks Index went UP +10.5% this past week but is still DOWN -17.9% YTD and DOWN -70.9% from its high in 2021.